Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP72367.RASTEFehpU2InmO1kX37Ey24eRPVqLhqNfs1KRjW3Kaa0130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72367.RASTEFehpU2InmO1kX37Ey24eRPVqLhqNfs1KRjW3Kaa0130_provenance.
• NP76997.RAAtIE-qRdOstb7xPNFMOd0bL35Yd2R1lQnu6yIR7YMZI130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76997.RAAtIE-qRdOstb7xPNFMOd0bL35Yd2R1lQnu6yIR7YMZI130_provenance.
• NP61005.RAXZknbxX9s9ygEeMbZ3vbaSJqkPT9Hzs0fOxgcWLMsC0130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61005.RAXZknbxX9s9ygEeMbZ3vbaSJqkPT9Hzs0fOxgcWLMsC0130_provenance.
• NP66298.RAyMcGnS6BUzgOM6w7DoHqnI6-l6F9OZv8Zx7g3t5DxLM130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66298.RAyMcGnS6BUzgOM6w7DoHqnI6-l6F9OZv8Zx7g3t5DxLM130_provenance.
• NP85629.RAe0doLmGeN5xxDyXWVQhGUS3a51qF-y0Xn4trt7k_Kj0130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85629.RAe0doLmGeN5xxDyXWVQhGUS3a51qF-y0Xn4trt7k_Kj0130_provenance.
• assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP78565.RAu3a-uap1kDUlaGFHYkZji2NHQYZj5Es3jtnJ8aXOpas130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78565.RAu3a-uap1kDUlaGFHYkZji2NHQYZj5Es3jtnJ8aXOpas130_provenance.
• NP90491.RAnoCwOZPcQs8svmo8XCo9JiJW0XNOXQ6LW3SqJ4CWayg130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90491.RAnoCwOZPcQs8svmo8XCo9JiJW0XNOXQ6LW3SqJ4CWayg130_provenance.
• NP155935.RAjHJ48MC5jQp-TT8g_TSmYW86iDA2Kjt3MxV6yCAceao130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155935.RAjHJ48MC5jQp-TT8g_TSmYW86iDA2Kjt3MxV6yCAceao130_provenance.
• NP100186.RA2iaXZnwTOXJ7S6YYpIHqg6cBaDSyr6wdUF_1c1mHtcs130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100186.RA2iaXZnwTOXJ7S6YYpIHqg6cBaDSyr6wdUF_1c1mHtcs130_provenance.
• NP761616.RAt3-WjYv-21y-FybgI6aa-u8wTJM5X2KA5N7R3L2VSHs130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761616.RAt3-WjYv-21y-FybgI6aa-u8wTJM5X2KA5N7R3L2VSHs130_provenance.
• NP113287.RAOmt-rr6Y2tnNy6bE_WVvlnU3KcuU6V4_FH_JPAJ0RR8130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113287.RAOmt-rr6Y2tnNy6bE_WVvlnU3KcuU6V4_FH_JPAJ0RR8130_provenance.
• NP155938.RAOEwS6wx2G0-6JDAzFAakDPklwsjssbhMDWSlGu5xOdE130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155938.RAOEwS6wx2G0-6JDAzFAakDPklwsjssbhMDWSlGu5xOdE130_provenance.
• NP155939.RAMyhGWPUJJcfQ6ynruvxQCQJyZO9NNZShlRpcYkY1MfM130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155939.RAMyhGWPUJJcfQ6ynruvxQCQJyZO9NNZShlRpcYkY1MfM130_provenance.
• NP155936.RA-g4YbH31leVl7t044HKaY052c1Oh_Ac-MMUw3bATwKk130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155936.RA-g4YbH31leVl7t044HKaY052c1Oh_Ac-MMUw3bATwKk130_provenance.
• NP155937.RA9Uxg5ztCNMkcoHLQ2nRstgmQnpJzm8Xl3DyaGGEJsIg130_assertion description "[A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155937.RA9Uxg5ztCNMkcoHLQ2nRstgmQnpJzm8Xl3DyaGGEJsIg130_provenance.